Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena Aebersold

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nature Communications|December 18, 2021
Sources of confidence in value-based choiceJeroen Brus, Helena Aebersold, Marcus Grueschow, et al.
American Journal of Epidemiology|March 20, 2026
Machine Learning Methods for Estimating Personalized Treatment Effects-Insights on validity from two large trialsHongruyu Chen, Helena Aebersold, Milo Alan Puhan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 23, 2023
Real-World Cost-Effectiveness of Pulmonary Vein Isolation for Atrial Fibrillation: A Target Trial ApproachMiquel Serra-Burriel, Helena Aebersold, Fabienne Foster-Witassek, et al.
Heart Rhythm|August 23, 2024
Is electrical cardioversion independently associated with infarcts on brain magnetic resonance imaging or clinical outcomes in patients with atrial fibrillation?Annina Stauber, Andreas Müller, Nikki Rommers, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 11, 2022
Association of pulmonary vein isolation and major cardiovascular events in patients with atrial fibrillationMarc Girod, Michael Coslovsky, Stefanie Aeschbacher, et al.
Journal of the American Heart Association|November 6, 2023
Longitudinal Changes in Health-Related Quality of Life in Patients With Atrial FibrillationFabienne Foster-Witassek, Helena Aebersold, Stefanie Aeschbacher, et al.
Heart (British Cardiac Society)|November 4, 2022
Patient clusters and cost trajectories in the Swiss Atrial Fibrillation cohortHelena Aebersold, Miquel Serra-Burriel, Fabienne Foster-Wittassek, et al.
BMJ Open|September 14, 2023
Estimating the cost impact of atrial fibrillation using a prospective cohort study and population-based controlsHelena Aebersold, Fabienne Foster-Witassek, Miquel Serra-Burriel, et al.
Swiss Medical Weekly|January 29, 2025
Impact of atrial fibrillation on productivity in working-age patients: an analysis of Swiss-AF prospective cohort study dataHelena Aebersold, Fabienne Foster-Witassek, Sina Amberg, et al.
Open Heart|February 1, 2024
Patients on vitamin K treatment: is switching to direct-acting oral anticoagulation cost-effective? A target trial on a prospective cohortHelena Aebersold, Fabienne Foster-Witassek, Stefanie Aeschbacher, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nature Communications|December 18, 2021
Sources of confidence in value-based choiceJeroen Brus, Helena Aebersold, Marcus Grueschow, et al.
American Journal of Epidemiology|March 20, 2026
Machine Learning Methods for Estimating Personalized Treatment Effects-Insights on validity from two large trialsHongruyu Chen, Helena Aebersold, Milo Alan Puhan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 23, 2023
Real-World Cost-Effectiveness of Pulmonary Vein Isolation for Atrial Fibrillation: A Target Trial ApproachMiquel Serra-Burriel, Helena Aebersold, Fabienne Foster-Witassek, et al.
Heart Rhythm|August 23, 2024
Is electrical cardioversion independently associated with infarcts on brain magnetic resonance imaging or clinical outcomes in patients with atrial fibrillation?Annina Stauber, Andreas Müller, Nikki Rommers, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 11, 2022
Association of pulmonary vein isolation and major cardiovascular events in patients with atrial fibrillationMarc Girod, Michael Coslovsky, Stefanie Aeschbacher, et al.
Journal of the American Heart Association|November 6, 2023
Longitudinal Changes in Health-Related Quality of Life in Patients With Atrial FibrillationFabienne Foster-Witassek, Helena Aebersold, Stefanie Aeschbacher, et al.
Heart (British Cardiac Society)|November 4, 2022
Patient clusters and cost trajectories in the Swiss Atrial Fibrillation cohortHelena Aebersold, Miquel Serra-Burriel, Fabienne Foster-Wittassek, et al.
BMJ Open|September 14, 2023
Estimating the cost impact of atrial fibrillation using a prospective cohort study and population-based controlsHelena Aebersold, Fabienne Foster-Witassek, Miquel Serra-Burriel, et al.
Swiss Medical Weekly|January 29, 2025
Impact of atrial fibrillation on productivity in working-age patients: an analysis of Swiss-AF prospective cohort study dataHelena Aebersold, Fabienne Foster-Witassek, Sina Amberg, et al.
Open Heart|February 1, 2024
Patients on vitamin K treatment: is switching to direct-acting oral anticoagulation cost-effective? A target trial on a prospective cohortHelena Aebersold, Fabienne Foster-Witassek, Stefanie Aeschbacher, et al.
Pageof 1